Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1868

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-1868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figr1

This text appears to be a list of interacting drugs and their effects on analytes like venlafaxine, along with recommendations for PK Fold Change and 90% CI. The list also includes advice on avoiding concomitant use or using with caution in certain patients.*

FDA Label Image

Figr2

This is a drug interaction table showing the effects of various drugs on each other when taken concomitantly. The table lists drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, and lithium, among others, and the recommended dose adjustments, if any. The table lists fold changes in PK (pharmacokinetics) and 90% CI (confidence interval). Additionally, the table mentions drugs that should be used with caution, and some should be avoided if possible.*

FDA Label Image

Figr3

This is a chart or table indicating recommendations for dosage adjustments for the drug venlafaxine based on specific patient populations, including those with hepatic impairment (cirrhosis, mild or moderate impairment), renal impairment (hemodialysis), CYP2D6 polymorphism, age (>60 years), and gender. The chart suggests reductions in dose for most of the patient populations mentioned, with some recommendations for individualization of dosing. The chart also includes information on changes in PK (pharmacokinetics) and fold change relative to reference values.*

FDA Label Image

Label (Lbl713351868)

This is a medication description for Venlafaxine HCL 75mg extended-release capsules manufactured by Annora Pharma Pvt. Ltd. They are pink and white in color and may cause drowsiness. The capsules should be stored at room temperature and kept away from children. The package contains 90 capsules and has an expiration date of MM/YY. The NDC number for this medication is 7133518681 03325901523487. The rest of the text appears to be a label from a supplier or distributor and is not relevant to the medication description.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.